| 000 | 01570 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516102354.0 | ||
| 264 | 0 | _c20150414 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1745-7254 | ||
| 024 | 7 |
_a10.1038/aps.2012.65 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Xian-ping | |
| 245 | 0 | 0 |
_aTolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cAug 2012 |
||
| 300 |
_a1085-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 |
_aCD11a Antigen _xmetabolism |
| 650 | 0 | 4 |
_aDrug Tolerance _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacokinetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLi, Jing | |
| 700 | 1 | _aYan, Heng | |
| 700 | 1 | _aZhou, Bo | |
| 700 | 1 | _aLi, Bo-hua | |
| 700 | 1 | _aQian, Wei-zhu | |
| 700 | 1 | _aHou, Sheng | |
| 700 | 1 | _aWang, Hao | |
| 700 | 1 | _aHao, Fei | |
| 700 | 1 | _aGuo, Ya-jun | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 33 _gno. 8 _gp. 1085-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/aps.2012.65 _zAvailable from publisher's website |
| 999 |
_c21945120 _d21945120 |
||